Literature DB >> 10473207

Dose distributions using kilovoltage x-rays and dose enhancement from iodine contrast agents.

A V Mesa1, A Norman, T D Solberg, J J Demarco, J B Smathers.   

Abstract

In x-ray phototherapy of brain tumours, the tumour is loaded with iodine and exposed to kilovoltage x-rays. Due to the high photoelectric cross sections of iodine, substantial photoelectric interactions occur. The flux of photoelectrons, characteristic x-rays and Auger electrons produce a localized dose enhancement. A modified computed tomography scanner, CTRx, can be used both for tumour localization and delivery of the dose enhancement therapy. Monte Carlo methods were employed to simulate the treatment of iodinated brain tumours with a CTRx. The calculated results reveal the effect of tumour iodine concentration on dose distribution, the degree of skull bone sparing with the application of multiple arcs, and the homogeneity of tumour dose distribution versus iodine concentration. A comparison with 10 MV stereotactic radiosurgery treatment shows the potential of CTRx treatment relative to conventional treatment modalities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473207     DOI: 10.1088/0031-9155/44/8/308

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  10 in total

Review 1.  Nanoscale radiation transport and clinical beam modeling for gold nanoparticle dose enhanced radiotherapy (GNPT) using X-rays.

Authors:  Piotr Zygmanski; Erno Sajo
Journal:  Br J Radiol       Date:  2015-12-07       Impact factor: 3.039

2.  Systematic survey of the dose enhancement in tissue-equivalent materials facing medium- and high-Z backscatterers exposed to X-rays with energies from 5 to 250 keV.

Authors:  M Seidenbusch; D Harder; D Regulla
Journal:  Radiat Environ Biophys       Date:  2014-03-15       Impact factor: 1.925

3.  Absolute perfusion measurements and associated iodinated contrast agent time course in brain metastasis: a study for contrast-enhanced radiotherapy.

Authors:  Layal Obeid; Pierre Deman; Alexandre Tessier; Jacques Balosso; François Estève; Jean-François Adam
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-22       Impact factor: 6.200

4.  The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources.

Authors:  Sang Hyun Cho; Bernard L Jones; Sunil Krishnan
Journal:  Phys Med Biol       Date:  2009-07-27       Impact factor: 3.609

5.  Intracerebral delivery of carboplatin in combination with either 6 MV photons or monoenergetic synchrotron X-rays are equally efficacious for treatment of the F98 rat glioma.

Authors:  Laure Bobyk; Magali Edouard; Pierre Deman; Julia Rousseau; Jean-François Adam; Jean-Luc Ravanat; François Estève; Jacques Balosso; Rolf F Barth; Hélène Elleaume
Journal:  J Exp Clin Cancer Res       Date:  2012-09-20

6.  Combined Megavoltage and Contrast-Enhanced Radiotherapy as an Intrafraction Motion Management Strategy in Lung SBRT.

Authors:  Daniel A Coronado-Delgado; Héctor M Garnica-Garza
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

7.  Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds.

Authors:  S Corde; A Joubert; J F Adam; A M Charvet; J F Le Bas; F Estève; H Elleaume; J Balosso
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

8.  Megavoltage X-ray Dose Enhancement with Gold Nanoparticles in Tumor Bearing Mice.

Authors:  Sayyed Hossein Mousavie Anijdan; Seyyed Rabi Mahdavi; Alireza Shirazi; Mohammad Ali Zarrinfard; Jamshid Hajati
Journal:  Int J Mol Cell Med       Date:  2013

Review 9.  Standards and Methodologies for Characterizing Radiobiological Impact of High-Z Nanoparticles.

Authors:  Anna Subiel; Reece Ashmore; Giuseppe Schettino
Journal:  Theranostics       Date:  2016-06-20       Impact factor: 11.556

10.  Methoxyamine Enhances 5-Fluorouracil-Induced Radiosensitization in Colon Cancer Cell Line HT29.

Authors:  Samideh Khoei; Roghayeh Poorabdollahi; Ahmad Mostaar; Fariborz Faeghi
Journal:  Cell J       Date:  2017-02-22       Impact factor: 2.479

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.